EMEA-002224-PIP01-17

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Synthetic double-stranded small interfering RNA (siRNA) oligonucleotide specific to the mRNA of the caspase 2 gene

Decision numberP/0394/2017
PIP numberEMEA-002224-PIP01-17
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Treatment of optic ischaemic neuropathy

Route(s) of administrationIntravitreal use
PIP applicant

Quark Pharmaceuticals, Inc.
Tel. +1 5103645121
E-mail: DCafaro@quarkpharma.com

Decision typeW: decision granting a waiver in all age groups for all conditions/indications

Decision